The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| COTY INC | COM CL A | 222070203 | 3,836 | 231,764 | SH | OTR | 1 | 0 | 231,764 | 0 | |
| EQUINIX INC | COM NEW | 29444U502 | 16,150 | 76,007 | SH | OTR | 1 | 0 | 76,007 | 0 | |
| IHS INC | CL A | 451734107 | 15,543 | 124,156 | SH | OTR | 1 | 0 | 124,156 | 0 | |
| TRANSDIGM GROUP INC | COM | 893641100 | 13,672 | 74,173 | SH | OTR | 1 | 0 | 74,173 | 0 | |
| VALEANT PHARMACEUTICALS INTL | COM | 91911K102 | 24,981 | 190,404 | SH | OTR | 1 | 0 | 190,404 | 0 | |
| VERISIGN INC | COM | 92343E102 | 9,258 | 167,953 | SH | OTR | 1 | 0 | 167,953 | 0 | |